--- title: "QHSLab, Inc. (USAQ.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/USAQ.US.md" symbol: "USAQ.US" name: "QHSLab, Inc." industry: "医疗信息服务" --- # QHSLab, Inc. (USAQ.US) | Item | Detail | |------|--------| | Industry | 医疗信息服务 | | Location | 美股市场 | | Website | [www.qhslab.com](https://www.qhslab.com) | ## Company Profile QHSLab, Inc.是一家医疗设备技术和软件即服务(SaaS)公司,提供评估和治疗慢性疾病及预防护理的工具,通过可报销的程序进行。该公司专注于基于价值的医疗保健、信息学和算法个性化医学,包括数字疗法、基于行为的远程患者监测以及慢性护理和预防医学。其数字医疗和临床决策支持及即时护理解决方案还支持非面对面的远程患者和治疗监测,解决慢性护理和预防医学问题。该公司提供质量健康评分实验室专家系统(QHSLab),这是一个基于云的医疗办公室和移动患者教育解决方案,为医生提供仪表板,以简化患者信息和业务操作;以及 AllergiEnd,这是一个用于初级护理环境中繁忙非过敏科医生的诊断和过敏免疫治疗系统 ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-18T04:30:13.000Z **Overall: C (0.42)** **Industry**: Health Care Technology | Metric | Value | |--------|-------| | Industry Ranking | 26 / 47 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 43.55% | | | Net Profit YoY | -563.52% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -17.81 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 10.89M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 2.61M | | **Multi Score**: C #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 81.68% | A | | Profit Margin | -14.80% | D | | Gross Margin | 66.97% | A | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 43.55% | A | | Net Profit YoY | -563.52% | E | | Total Assets YoY | -1.70% | D | | Net Assets YoY | -82.22% | E | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -675.87% | E | | OCF YoY | 43.55% | A | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.49 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 135.22% | E | ```chart-data:radar { "title": "Longbridge Financial Score - QHSLab, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "81.68%", "rating": "A" }, { "name": "Profit Margin", "value": "-14.80%", "rating": "D" }, { "name": "Gross Margin", "value": "66.97%", "rating": "A" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "43.55%", "rating": "A" }, { "name": "Net Profit YoY", "value": "-563.52%", "rating": "E" }, { "name": "Total Assets YoY", "value": "-1.70%", "rating": "D" }, { "name": "Net Assets YoY", "value": "-82.22%", "rating": "E" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "-675.87%", "rating": "E" }, { "name": "OCF YoY", "value": "43.55%", "rating": "A" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.49", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "135.22%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B | | 02 | Waystar (US.WAY) | C | A | D | B | B | B | | 03 | Doximity (US.DOCS) | A | B | C | A | C | B | | 04 | Phreesia (US.PHR) | C | B | A | B | D | B | | 05 | 健康流科技 (US.HSTM) | B | C | B | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -28.15 | 36/42 | - | - | - | | PB | -17.81 | 38/42 | - | - | - | | PS (TTM) | 4.16 | 25/42 | 1.55 | 1.04 | 0.89 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2023-04-03T04:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 100% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 0.72 | ## References - [Company Overview](https://longbridge.com/en/quote/USAQ.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/USAQ.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/USAQ.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.